Navigation Links
NGO Files Pre-Grant Opposition Against Anti-HIV Drug, Combivir

A pre-grant opposition has been filed against the anti-HIV drug, Combivir, manufactured by GlaxoSmithKline, a leading pharmaceutical company //. The Manipur Network of Positive People (MNP+) and the Indian Network of People Living with HIV/AIDS have lodged the complaint at the Kolkata patent office.

The drug formulation is a combination of two essential anti-HIV drugs Lamivudine and Zidovudine and is not a new formulation, said a release. The grant of a patent is believed to make the anti-retroviral treatment expensive for patients afflicted with the deadly disease.

'We are objecting to the patenting of Combivir because it is not a new invention but simply the combination of two existing drugs,' said K K Abraham, president, INP+.

A similar opposition was raised regarding patenting anti-cancer drug, Gleevac, manufactured by Novartis. The patent was turned down subsequently as it was found to nothing more than a new form of an old drug.

Combivir is one of the anti-retroviral drugs used by numerous AIDS/HIV organizations, worldwide. A fixed dose combination of the drug is used in several projects targeted at provision of cheap and effective AIDS/HIV treatment to those who cannot afford the same.

In India, more than 5.1 million people are afflicted with AIDS/HIV and a majority of these are solely dependent on the generic drugs provided by the national HIV/AIDS treatment program. The issue of a patent can lead to domination with respect to drug manufacture, thereby restricting the production of effective and affordable drug alternatives.


'"/>




Page: 1

Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Venus Remedies Files 5th International Patent Application
3. AIIMS Official Files Complaint Against Venugopal
4. Glaxo Files Cancer Drug For Approval With FDA
5. Queensland Opposition not happy over hiring consultancy
6. Opposition: Government turned a deaf ear to warnings about dwindling health care services
7. Kleins Third Way Has Tough Opposition
8. Opposition to Compulsory Fortification of Bread with Folic Acid
9. Opposition against Amendments in the Intellectual Property Law
10. Madhya Pradesh Begins Surya Namaskar Amid Muslim Opposition
11. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... , ... May 31, 2016 , ... Throughout the day, adults often find themselves reaching ... and awareness, but what they could be reaching for instead is a cup of Matcha ... are grown in Japan. This sacred tea is harvested from early June to mid-July, when ...
(Date:5/31/2016)... ... May 31, 2016 , ... Presence ... it has been included by Gartner, Inc. in the Contact Center Infrastructure Magic ... Contact Center Infrastructure technologies, some of which include: Computer-telephony integration (CTI)/Web services ...
(Date:5/31/2016)... TEXAS (PRWEB) , ... May 31, 2016 , ... ... live in Greater Houston Healthconnect’s (Healthconnect) regional health information exchange, which enables physicians ... medical records for their patients from other participating organizations in the exchange. SJMC’s ...
(Date:5/31/2016)... GA (PRWEB) , ... May 31, 2016 , ... ... readmissions using a mix of advanced Artificial Intelligence (AI) and the latest in ... solution. The medical center is integrating predictive analytic outputs directly into the clinical ...
(Date:5/31/2016)... ... 31, 2016 , ... DDL, Inc. announced today it has expanded the scope ... include ISO 594-1 and ISO 594-2 testing for conical (Luer) fittings. , A ... two medical devices (e.g. a syringe and hypodermic needle) that carry small volumes of ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 The global dental bone ... a CAGR of 10.6% within a forecast period from ... bn in 2013. Owing to favorable factors at play ... bn by the end of this forecast period, i.e. ... holistic representation in a research report published by Transparency ...
(Date:5/31/2016)... NESS ZIONA, Israel , ... a regenerative medicine company utilizing its proprietary plant-based rhCollagen ... has received authorization from the Chief Scientist of ... approximately 50% of its NIS 12 million development project ... million, measurably higher than last year,s authorized grant, which ...
(Date:5/30/2016)... , May 30, 2016 ... research report "Healthcare Biometrics Market by Technology ... Voice)), Multifactor, Multimodal), Application (Workforce Management), End ... to 2021", published by MarketsandMarkets, the market ... by 2021 from USD 1,182.6 Million by ...
Breaking Medicine Technology: